These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. ZAC1 and SSTR2 are downregulated in non-functioning pituitary adenomas but not in somatotropinomas. Vieria Neto L, Wildemberg LE, Colli LM, Kasuki L, Marques NV, Moraes AB, Gasparetto EL, Takiya CM, Castro M, Gadelha MR. PLoS One; 2013; 8(10):e77406. PubMed ID: 24098585 [Abstract] [Full Text] [Related]
7. Somatostatin Receptor Expression in GH-Secreting Pituitary Adenomas Treated with Long-Acting Somatostatin Analogues in Combination with Pegvisomant. Franck SE, Gatto F, van der Lely AJ, Janssen JAMJL, Dallenga AHG, Nagtegaal AP, Hofland LJ, Neggers SJCMM. Neuroendocrinology; 2017; 105(1):44-53. PubMed ID: 27455094 [Abstract] [Full Text] [Related]
8. Somatostatin receptor subtype gene expression in pituitary adenomas. Miller GM, Alexander JM, Bikkal HA, Katznelson L, Zervas NT, Klibanski A. J Clin Endocrinol Metab; 1995 Apr; 80(4):1386-92. PubMed ID: 7714115 [Abstract] [Full Text] [Related]
9. Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study. Iacovazzo D, Carlsen E, Lugli F, Chiloiro S, Piacentini S, Bianchi A, Giampietro A, Mormando M, Clear AJ, Doglietto F, Anile C, Maira G, Lauriola L, Rindi G, Roncaroli F, Pontecorvi A, Korbonits M, De Marinis L. Eur J Endocrinol; 2016 Feb; 174(2):241-50. PubMed ID: 26586796 [Abstract] [Full Text] [Related]
11. Effects of somatostatin on somatotroph adenomas of the human pituitary: An in vitro functional and morphological study. Asa SL, Felix I, Kovacs K, Ramyar L. Endocr Pathol; 1990 Dec; 1(4):228-235. PubMed ID: 32357614 [Abstract] [Full Text] [Related]